13F-HR filed by New Leaf Venture Partners, L.L.C.
New Leaf Venture Partners, L.L.C. filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-06, with 21 holding rows worth $202,904,000.
- Accession
- 0000950123-22-004719
- Filer
- CIK 1631614
- Filed
- 2022-05-06
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 21 entries on the cover page, a total value of $202,904,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $202,904,000 with VALUE read as thousands by filing date, 13F file number 028-16681. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARVINAS INC | 04335A105 | COM | 1,289,521 | $86,785,000 | thousands by filing date | |
| RALLYBIO CORP | 75120L100 | COM | 2,301,603 | $16,065,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 3,156,699 | $15,689,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,553,661 | $15,071,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 1,209,571 | $11,213,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 556,693 | $10,650,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 2,497,922 | $7,744,000 | thousands by filing date | |
| APTINYX INC | 03836N103 | COM | 3,290,079 | $7,468,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 1,224,600 | $5,609,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 339,569 | $4,839,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U107 | COM | 125,511 | $4,023,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 501,530 | $3,756,000 | thousands by filing date | |
| AMRYT PHARMA LTD - SPNR ADR | 03217L106 | COMMON EQUITY | 449,737 | $3,719,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 141,000 | $3,095,000 | thousands by filing date | |
| RENOVACOR INC | 75989E106 | COM | 672,288 | $2,851,000 | thousands by filing date | |
| Aravive Inc | 03890D108 | Common / Ordinary Stock | 946,423 | $1,827,000 | thousands by filing date | |
| PDS BIOTECHNOLOGY CORP | 70465T107 | COM | 117,242 | $726,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 335,000 | $586,000 | thousands by filing date | |
| ITERUM THERAPEUTICS PLC SHS NEW | G6333L101 | Stock | 1,456,303 | $517,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 315,550 | $417,000 | thousands by filing date | |
| ADDEX THERAPEUTICS LTD | 00654J107 | SPONSORED ADS | 50,000 | $254,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-004719 | this filing | 2022-05-06 | acceptance time not in the bulk data set |